Results 51 to 60 of about 430,017 (187)

Neuromodulation for Neurogenic Bladder [PDF]

open access: yes, 2013
Although neuromodulation is well established for the treatment of non-neurogenic lower urinary tract symptoms, recent literature supports its use in the patient having LUTS associated with a neurologic condition.
Powell, C.R.
core   +1 more source

Vesicostomy for Renal and Upper Urinary Tract Protection in Children with Neurogenic Bladder: A Comprehensive Review [PDF]

open access: yesStudies in Multidisciplinary Medical Research
Children with neurogenic bladder, particularly due to spina bifida, are at high risk of elevated intravesical pressures, vesicoureteral reflux, and progressive upper urinary tract deterioration, which can lead to chronic kidney disease.
Hirbod Hadizadeh Moallem   +2 more
doaj   +1 more source

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta‐Analysis

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad   +4 more
wiley   +1 more source

The Worldwide Economic Impact of Neurogenic Bladder

open access: yes, 2015
Costs of neurogenic bladder vary widely and depend on a number of factors including severity of disease, symptomatology, patient insurance, and devices required.
Flack, Chandra, Powell, C.R.
core   +1 more source

Effects of 4-Ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate Hydrochloride, a Metabolite of Oxybutynin, on Bladder Specimens and Rhythmic Bladder Contraction in Rats in Comparison With Oxybutynin

open access: yesJournal of Pharmacological Sciences, 2004
Oxybutynin has been used for neurogenic bladder disorders and is known to have anti-cholinergic and antispasmodic properties. However, the anti-cholinergic and antispasmodic properties of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate ...
Masayuki Uchida   +3 more
doaj   +1 more source

Advancing Personalized Care for Neurogenic Bladder: The Case for Continent Urinary Diversion

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Neurogenic lower urinary tract dysfunction (NLUTD) with a poorly compliant bladder that is refractory to minimally invasive therapies (MIT) represents an “end‐stage” phenotype in which the principal objectives are durable upper urinary tract protection and restoration of continence with acceptable long‐term morbidity.
Francis A. Jefferson, Maude E. Carmel
wiley   +1 more source

Glass half full: Non-invasive bladder biosensors for urinary volume monitoring in the neurogenic pediatric population

open access: yesJournal of Pediatric Rehabilitation Medicine
Purpose The goal was to elucidate and present the current landscape of bladder biosensor technology for urinary volume monitoring in the management of neurogenic bladder.
Serena Ly, Eric A Kurzrock
doaj   +1 more source

Use of Cadaveric Pericardial Tissue in the Surgical Treatment of Neurogenic Bladder

open access: yesCase Reports in Urology, 2019
The surgical treatments for neurogenic bladder are extremely variable. The lack of specific treatment guidelines makes this disease process even more challenging to treat.
Madison Caja   +4 more
doaj   +1 more source

Urodynamic Voiding Patterns in Multiple Sclerosis

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel   +5 more
wiley   +1 more source

PREDICT‐PD: A Two‐Stage Approach to Early Identification of Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Sasivimol Virameteekul   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy